{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T07:23:08Z","timestamp":1772090588547,"version":"3.50.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Despite the activity of the COVID-19 pandemic being lower in the recent years, COVID-associated threat, long COVID (LC). Its clinical presentation includes nearly 200 symptoms affecting cardiovascular, respiratory, nervous systems, endocrine organs, urinary tract, and gastrointestinal systems. Cytokines serve as important biomarkers for assessing the level of immune system involvement and dysregulation in LC. Most studies on cytokine network and cytokine interactions usually address more traditional methods of statistical analysis with comparison criteria, discriminant analysis, regression. But multiplex cytokine analysis includes dozens of parameters, and requires complex assessment of the network as a whole.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed data of cytokine multiplex analysis of 289 patients with COVID-19, 44 patients with LC and 51 healthy donors. PCA we identified cyotkines with the highest importance rate, and further investigated  between them with the use of 3D mapping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three key clusters were identified: cluster A - IL-13, CCL7\/MCP-3, IL-4; cluster B -  IL-18, CCL2\/MCP-1, CCL4\/MIP-1\u03b2, CXCL8\/IL-8, M-CSF, and cluster C - sCD40L, CXCL1\/GRO\u03b1, PDGF-AA, EGF, FGF-2, FLT-3L, IL-7, IL-17F.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The coordinated interactions within these clusters reveal a complex immunopathology behind LC: clsuter A repsresenting local immune responses, cluster B for neuroinflammatory processes, and cluster C for changes in the blood vessels. The results, however, leave an opening for further investigatoin and interpretation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1717107","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:55:19Z","timestamp":1772088919000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Principal component analysis of cytokine signature in COVID-19 and Long COVID"],"prefix":"10.3389","volume":"17","author":[{"given":"Zoia R.","family":"Korobova","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Immunology, Saint Petersburg Pasteur Institute","place":["Saint Petersburg, Russia"]},{"name":"Department of Immunology, Faculty of Medicine, First Pavlov State Medical University of St. Petersburg","place":["Saint Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areg A.","family":"Totolian","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology, Saint Petersburg Pasteur Institute","place":["Saint Petersburg, Russia"]},{"name":"Department of Immunology, Faculty of Medicine, First Pavlov State Medical University of St. Petersburg","place":["Saint Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Al-Aly","year":"2024","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01136-X","article-title":"Long COVID: a clinical update","volume":"404","author":"Greenhalgh","year":"2024","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1038\/s41467-025-59012-w","article-title":"The risk of Long Covid symptoms: a systematic review and meta-analysis of controlled studies","volume":"16","author":"O\u2019Mahoney","year":"2025","journal-title":"Nat Commun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1186\/s12967-023-04588-4","article-title":"Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME\/CFS identified by combinatorial analysis","volume":"21","author":"Taylor","year":"2023","journal-title":"J Trans Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1011936","article-title":"A review of cytokine-based pathophysiology of Long COVID symptoms","volume":"10","author":"Low","year":"2023","journal-title":"Front Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.15789\/2220-7619-PVO-2043","article-title":"Predictive value of specific cytokines for lethal COVID-19 outcome","volume":"12","author":"Arsentieva","year":"2023","journal-title":"Russian J Infect Immun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-012-0432-1","article-title":"Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma","volume":"33","author":"Kowalska","year":"2012","journal-title":"Tumor Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e24689","DOI":"10.1002\/jcla.24689","article-title":"Logistic regression models of cytokines in differentiating vitreoretinal lymphoma from uveitis","volume":"36","author":"Tian","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520926882","article-title":"Cytokine clusters as potential diagnostic markers of disease activity and renal involvement in systemic lupus erythematosus","volume":"48","author":"Park","year":"2020","journal-title":"J Int Med Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e39677","DOI":"10.1371\/journal.pone.0039677","article-title":"Principal component analysis of the cytokine and chemokine response to human traumatic brain injury","volume":"7","author":"Helmy","year":"2012","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214146","article-title":"Cytokine profiling in different SARS-coV-2 genetic variants","volume":"23","author":"Korobova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169058","article-title":"A comparative study of the plasma chemokine profile in COVID-19 patients infected with different SARS-coV-2 variants","volume":"23","author":"Korobova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178432","article-title":"Redefining normal: cytokine dysregulation in long COVID and the post-pandemic healthy donors","volume":"26","author":"Korobova","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e21949","DOI":"10.1371\/journal.pone.0021949","article-title":"IL-1\u03b2 Promotes TGF-\u03b21 and IL-2 dependent foxp3 expression in regulatory T cells","volume":"6","author":"Ganesh","year":"2011","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1582783","article-title":"Acute COVID-19 and LongCOVID syndrome - molecular implications for therapeutic strategies - review","volume":"16","author":"Michalak","year":"2025","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2755246","article-title":"Associations between serum interleukins (IL-1\u03b2, IL-2, IL-4, IL-6, IL-8, and IL-10) and disease severity of COVID-19: A systematic review and meta-analysis","volume":"2022","author":"Chang","year":"2022","journal-title":"BioMed Res Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47040245","article-title":"B cell dynamics and transitional B cells in long COVID","volume":"47","author":"Korobova","year":"2025","journal-title":"Curr Issues Mol Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e150107","DOI":"10.1172\/jci.insight.150107","article-title":"IL-13 is a driver of COVID-19 severity","volume":"6","author":"Donlan","year":"2021","journal-title":"JCI Insight"},{"key":"B20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40249-023-01086-z","article-title":"Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis","volume":"12","author":"Yin","year":"2023","journal-title":"Infect Dis Poverty"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106241","article-title":"The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19","volume":"89","author":"Gottlieb","year":"2024","journal-title":"J Infect"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1488745","article-title":"Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection","volume":"15","author":"Lokau","year":"2025","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076142","article-title":"Prospective roles of tumor necrosis factor-alpha (TNF-\u03b1) in COVID-19: prognosis, therapeutic and management","volume":"24","author":"Mohd Zawawi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.702507","article-title":"IL-10 and IL-12 (P70) levels predict the risk of covid-19 progression in hypertensive patients: insights from the BRACE-CORONA trial","volume":"8","author":"Moll-Bernardes","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B25","first-page":"672","article-title":"Cytokine deficiencies in patients with long-COVID","volume":"13","author":"Williams","year":"2022","journal-title":"J Clin Cell Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2011.10.006","article-title":"The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use","volume":"14","author":"Perera","year":"2012","journal-title":"Microbes Infect"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12030391","article-title":"Resistin and IL-15 as predictors of invasive mechanical ventilation in COVID-19 pneumonia irrespective of the presence of obesity and metabolic syndrome","volume":"12","author":"Perpi\u00f1an","year":"2022","journal-title":"J Pers Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111980","article-title":"Interleukin-17A (IL-17A): A silent amplifier of COVID-19","volume":"142","author":"Maione","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.922422","article-title":"Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome","volume":"12","author":"Queiroz","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08830189809084486","article-title":"Interleukin-4 and interleukin-13: their similarities and discrepancies","volume":"17","author":"Chomarat","year":"1998","journal-title":"Int Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113000","article-title":"Significance of interleukin (IL)-4 and IL-13 in inflammatory arthritis","volume":"10","author":"Iwaszko","year":"2021","journal-title":"Cells"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2025.100288","article-title":"The role of soluble CD40L in autoimmune diseases","volume":"10","author":"Mabrouk","year":"2025","journal-title":"J Trans Autoimmun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/JLB.3COVA0820-410RRR","article-title":"Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex","volume":"109","author":"Petrey","year":"2021","journal-title":"J Leukocyte Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cyto.2015.05.014","article-title":"IL-4 and IL-13 signaling in allergic airway disease","volume":"75","author":"Gour","year":"2015","journal-title":"Cytokine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e4928","DOI":"10.7717\/peerj.4928","article-title":"Crucial biological functions of CCL7 in cancer","volume":"6","author":"Liu","year":"2018","journal-title":"PeerJ"},{"key":"B38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12933-022-01626-1","article-title":"CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease","volume":"21","author":"Chang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2021.100370","article-title":"CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium","volume":"18","author":"Estevao","year":"2021","journal-title":"Brain Behav Immun - Health"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208231200","article-title":"Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2","volume":"278","author":"Heidemann","year":"2003","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2025.115192","article-title":"CCL2\/CCR2 signaling-mediated microglial migration leads to cerebral small vessel dysfunction in chronic hypertension model rats","volume":"387","author":"Koizumi","year":"2025","journal-title":"Exp Neurol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00499","article-title":"New therapeutic avenues of mCSF for brain diseases and injuries","volume":"12","author":"Pons","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-9","article-title":"Interleukin 18 in the CNS","volume":"7","author":"Alboni","year":"2010","journal-title":"J Neuroinflamm"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.747324","article-title":"Interleukin-7 biology and its effects on immune cells: mediator of generation, differentiation, survival, and homeostasis","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01558","article-title":"Biology of interleukin-17 and its pathophysiological significance in sepsis","volume":"11","author":"Ge","year":"2020","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e22286","DOI":"10.1096\/fj.202101837R","article-title":"Epidermal growth factor deficiency predisposes to progressive renal disease","volume":"36","author":"Zeid","year":"2022","journal-title":"FASEB J"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-020-05831-7","article-title":"Intussusceptive angiogenesis in Covid-19: hypothesis on the significance and focus on the possible role of FGF2","volume":"47","author":"Meini","year":"2020","journal-title":"Mol Biol Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071525","article-title":"The flt3L\/flt3 axis in dendritic cell biology and cancer immunotherapy","volume":"13","author":"Cueto","year":"2021","journal-title":"Cancers"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2024.11.013","article-title":"The lung and winding road: inflammation-driven platelet reactivity in long COVID","volume":"10","author":"Roweth","year":"2025","journal-title":"JACC: Basic to Trans Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jacbts.2024.09.007","article-title":"Low-grade inflammation in long COVID syndrome sustains a persistent platelet activation associated with lung impairment","volume":"10","author":"Brambilla","year":"2024","journal-title":"JACC: Basic to Trans Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/covid5080112","article-title":"sCD40L-mediated platelet activation and thromboinflammation during SARS-coV-2 infection: clinical and experimental evidence","volume":"5","author":"Allaoui","year":"2025","journal-title":"COVID"},{"key":"B52","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12985-021-01680-3","article-title":"Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection","volume":"18","author":"Hamzeh-Cognasse","year":"2021","journal-title":"Virol J"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2004.03.004","article-title":"PDGF and cardiovascular disease","volume":"15","author":"Raines","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1159\/000430914","article-title":"Chemokine CXCL1-mediated neutrophil trafficking in the lung: role of CXCR2 activation","volume":"7","author":"Sawant","year":"2015","journal-title":"J Innate Immun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1717107\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:55:20Z","timestamp":1772088920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1717107\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2026.1717107"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1717107","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"article-number":"1717107"}}